Search

everythinglearnresearchcommunity

for

Search:↓

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Women with PCOS have higher cardiometabolic risks.

Balding people may have higher heart disease risk.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Skin tags in obese individuals may indicate higher cardiovascular risk.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

People with plantar corns and calluses may have a higher chance of having metabolic syndrome.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Darkened knuckles can be an early sign of insulin resistance.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Relatives of women with PCOS symptoms are more likely to have similar health issues.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.